D.J., H., H.J., W., A.M., W., S.S., B., L., T., N., R., . . . SCHOOL, D. M. (2018). Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner. BioMed Central .
Chicago Style CitationD.J., Hausenloy, Whittington H.J., Wynne A.M., Begum S.S., Theodorou L., Riksen N., Mocanu M.M., Yellon D.M., and DUKE-NUS MEDICAL SCHOOL. Dipeptidyl Peptidase-4 Inhibitors and GLP-1 Reduce Myocardial Infarct Size in a Glucose-dependent Manner. BioMed Central , 2018.
MLA CitationD.J., Hausenloy, et al. Dipeptidyl Peptidase-4 Inhibitors and GLP-1 Reduce Myocardial Infarct Size in a Glucose-dependent Manner. BioMed Central , 2018.
Warning: These citations may not always be 100% accurate.